aTyr Pharma | LIFE - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Ardelyx USD 31.21M 36.79M 2026-03
aTyr Pharma USD 16.16M 6.15M 2026-06
Biogen USD 1.28B 2.1B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Cipla INR 10.18B 2.22B 2026-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 12.43M 78.16M 2026-03
CSL USD 2.16B 633M 2025-06
Curis USD 10.14M 10.14M 2025-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
Grifols EUR 979.78M 334.84M 2024-12
Lakefront Biotherapeutics EUR 135.95M 69.15M 2026-06
Novartis USD 7.62B 739M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
United Therapeutics USD 1.8B 523.5M 2026-06